Safety of antivascular endothelial growth factor administration in the ocular anterior segment in pterygium and neovascular glaucoma treatment: Systematic review and meta-analysis

BACKGROUND: Anti-VEGF agents has been widely used in ocular diseases, but its safety for treating anterior segment disorders, the conclusions are controversial. METHODS: Several major databases, including CENTRAL, MEDLINE, and EMBASE, were searched. Safety data from 18 randomized controlled trials (...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shi-tong, Tian, Bi-shan, Xiao, Ou, Yang, Yong-juan, Zhou, Shi-you
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112962/
https://www.ncbi.nlm.nih.gov/pubmed/30142821
http://dx.doi.org/10.1097/MD.0000000000011960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112962/
https://www.ncbi.nlm.nih.gov/pubmed/30142821
http://dx.doi.org/10.1097/MD.0000000000011960

Ejemplares similares